Acute myeloid leukemia in older adults : PIH: How to improve the outcome of adult acute myeloid leukemia?YANADA, Masamitsu; NAOE, Tomoki.International journal of hematology. 2012, Vol 96, Num 2, pp 186-193, issn 0925-5710, 8 p.Article

Allogeneic hematopoietic stem cell transplantation as part of postremission therapy improves survival for adult patients with high-risk acute lymphoblastic leukemia : A metaanalysisYANADA, Masamitsu; MATSUO, Keitaro; SUZUKI, Takeshi et al.Cancer. 2006, Vol 106, Num 12, pp 2657-2663, issn 0008-543X, 7 p.Article

Recent advances in the treatment of Philadelphia chromosome-positive acute lymphoblastic leukemiaYANADA, Masamitsu; OHNO, Ryuzo; NAOE, Tomoki et al.International journal of hematology. 2009, Vol 89, Num 1, pp 3-13, issn 0925-5710, 11 p.Article

Clinical significance of FLT3 in leukemiaKIYOI, Hitoshi; YANADA, Masamitsu; OZEKI, Kazutaka et al.International journal of hematology. 2005, Vol 82, Num 2, pp 85-92, issn 0925-5710, 8 p.Article

Randomized controlled trials of treatments for hematologic malignancies : Study characteristics and outcomesYANADA, Masamitsu; NARIMATSU, Hiroto; SUZUKI, Takeshi et al.Cancer. 2007, Vol 110, Num 2, pp 334-339, issn 0008-543X, 6 p.Article

Cloning and characterization of the murine antithrombin geneNAKAYAMA, Yukiko; KOJIMA, Tetsuhito; TAKAGI, Akira et al.Thrombosis research. 2000, Vol 100, Num 3, pp 179-183, issn 0049-3848Article

Potential Cure of Acute Myeloid Leukemia : Analysis of 1069 Consecutive Patients in First Complete RemissionYANADA, Masamitsu; GARCIA-MANERO, Guillermo; BORTHAKUR, Gautam et al.Cancer. 2007, Vol 110, Num 12, pp 2756-2760, issn 0008-543X, 5 p.Article

Prognosis of acute myeloid leukemia harboring monosomal karyotype in patients treated with or without allogeneic hematopoietic cell transplantation after achieving complete remissionYANADA, Masamitsu; KUROSAWA, Saiko; TAKAMATSU, Yasushi et al.Haematologica (Roma). 2012, Vol 97, Num 6, pp 915-918, issn 0390-6078, 4 p.Article

High complete remission rate and promising outcome by combination of imatinib and chemotherapy for newly diagnosed BCR-ABL-positive acute lymphoblastic leukemia : A phase II study by the Japan adult leukemia study groupYANADA, Masamitsu; TAKEUCHI, Jin; MARUTA, Atsuo et al.Journal of clinical oncology. 2006, Vol 24, Num 3, pp 460-466, issn 0732-183X, 7 p.Article

The Demarcation Between Younger and Older Acute Myeloid Leukemia Patients: A Pooled Analysis of 3 Prospective StudiesYANADA, Masamitsu; OHTAKE, Shigeki; KANBAYASHI, Hiroyuki et al.Cancer. 2013, Vol 119, Num 18, pp 3326-3333, issn 0008-543X, 8 p.Article

Clinical significance of minimal residual disease in patients with t(8;21) acute myeloid leukemia in JapanNARIMATSU, Hiroto; IINO, Masaki; YANADA, Masamitsu et al.International journal of hematology. 2008, Vol 88, Num 2, pp 154-158, issn 0925-5710, 5 p.Article

Impact of antithrombin deficiency in thrombogenesis: lipopolysaccharide and stress-induced thrombus formation in heterozygous antithrombin-deficient miceYANADA, Masamitsu; KOJIMA, Tetsuhito; ISHIGURO, Kazuhiro et al.Blood. 2002, Vol 99, Num 7, pp 2455-2458, issn 0006-4971Article

Micafungin for empirical antifungal therapy in patients with febrile neutropenia: multicenter phase 2 studyMIZUNO, Hiroki; SAWA, Masashi; GOTO, Emi et al.International journal of hematology. 2013, Vol 98, Num 2, pp 231-236, issn 0925-5710, 6 p.Article

Combination of intensive chemotherapy and imatinib can rapidly induce high-quality complete remission for a majority of patients with newly diagnosed BCR-ABL-positive acute lymphoblastic leukemiaTOWATARI, Masayuki; YANADA, Masamitsu; JINNAI, Itsuro et al.Blood. 2004, Vol 104, Num 12, pp 3507-3512, issn 0006-4971, 6 p.Article

Nilotinib as frontline therapy for patients with newly diagnosed Ph+ chronic myeloid leukemia in chronic phase: results from the Japanese subgroup of ENESTndNAKAMAE, Hirohisa; SHIBAYAMA, Hirohiko; AMAGASAKI, Taro et al.International journal of hematology. 2011, Vol 93, Num 5, pp 624-632, issn 0925-5710, 9 p.Article

Karyotype at diagnosis is the major prognostic factor predicting relapse-free survival for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia treated with imatinib-combined chemotherapyYANADA, Masamitsu; TAKEUCHI, Jin; MARUTA, Atsuo et al.Haematologica (Roma). 2008, Vol 93, Num 2, pp 287-290, issn 0390-6078, 4 p.Article

Prediction of risk of disease recurrence by genome-wide cDNA microarray analysis in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia treated with imatinib-combined chemotherapyZEMBUTSU, Hitoshi; YANADA, Masamitsu; OHNO, Ryuzo et al.International journal of oncology. 2007, Vol 31, Num 2, pp 313-322, issn 1019-6439, 10 p.Article

Prospective monitoring of BCR-ABL1 transcript levels in patients with Philadelphia chromosome-positive acute lymphoblastic leukaemia undergoing imatinib-combined chemotherapyYANADA, Masamitsu; SUGIURA, Isamu; NISHII, Kazuhiro et al.British journal of haematology. 2008, Vol 143, Num 4, pp 503-510, issn 0007-1048, 8 p.Article

Severe hepatitis associated with varicella zoster virus infection in a patient with diffuse large B cell lymphoma treated with rituximab-CHOP chemotherapyOKAMOTO, Akinao; ABE, Akihiro; YAMAMOTO, Yukiya et al.International journal of hematology. 2012, Vol 96, Num 4, pp 516-520, issn 0925-5710, 5 p.Article

Hematopoietic stem cell transplantation for acute promyelocytic leukemia in second or third complete remission : a retrospective analysis in the Nagoya Blood and Marrow Transplantation GroupKOHNO, Akio; MORISHITA, Yoshihisa; SAO, Hiroshi et al.International journal of hematology. 2008, Vol 87, Num 2, pp 210-216, issn 0925-5710, 7 p.Article